StroMed/platelet rich plasma / VivaTech - LARVOL DELTA

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Aug 2025 ➔ Aug 2026 | Trial primary completion date: Aug 2025 ➔ Aug 2026

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Aug 2025 ➔ Aug 2026 | Trial primary completion date: Aug 2025 ➔ Aug 2026

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Aug 2025 ➔ Aug 2026 | Trial primary completion date: Aug 2025 ➔ Aug 2026

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Jul 2022 ➔ Aug 2025 | Trial primary completion date: Jul 2022 ➔ Aug 2025

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Jul 2022 ➔ Aug 2025 | Trial primary completion date: Jul 2022 ➔ Aug 2025

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee (clinicaltrials.gov) - P2 | N=4000 | Recruiting | Sponsor: VivaTech International, Inc. | Trial completion date: Jul 2022 ➔ Aug 2025 | Trial primary completion date: Jul 2022 ➔ Aug 2025

Trial completion date • Trial primary completion date • Immunology • Inflammation • Osteoarthritis • Pain • Rheumatology

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Hip (clinicaltrials.gov) - P2; N=4000; Recruiting; Sponsor: VivaTech International, Inc.; Trial completion date: Jul 2020 ➔ Jul 2022; Trial primary completion date: Jul 2019 ➔ Jul 2022

Clinical • Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology • MRI

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder (clinicaltrials.gov) - P2; N=4000; Recruiting; Sponsor: VivaTech International, Inc.; Trial completion date: Jul 2020 ➔ Jul 2022; Trial primary completion date: Jul 2019 ➔ Jul 2022

Clinical • Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology • MRI

Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee (clinicaltrials.gov) - P2; N=4000; Recruiting; Sponsor: VivaTech International, Inc.; Trial completion date: Jul 2020 ➔ Jul 2022; Trial primary completion date: Jul 2019 ➔ Jul 2022

Clinical • Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology • MRI